Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Tablet containing everolimus, and preparation method thereof

A technology for everolimus and tablets, which is applied to the field of tablets containing everolimus and its preparation, can solve problems such as potential safety hazards, influence on product properties, etc., and achieves improved safety, convenient operation and simple preparation process Effect

Active Publication Date: 2014-02-19
SHANDONG NEWTIME PHARMA
View PDF3 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The antioxidant di-tert-butyl-p-cresol is added to Novartis's marketed preparations, which affects the properties of the product and brings safety risks to patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tablet containing everolimus, and preparation method thereof
  • Tablet containing everolimus, and preparation method thereof
  • Tablet containing everolimus, and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] 1.1 Preparation of everolimus solid dispersion

[0031] Everolimus 1 part

[0032] 4 parts absolute ethanol

[0033] Hydroxypropyl cellulose 0.3 parts

[0034] Preparation process: After dissolving everolimus in absolute ethanol, add hydroxypropyl cellulose, stir to dissolve, and then use supercritical fluid technology to prepare, and use supercritical fluid rapid expansion method to depressurize the solution through the nozzle and capillary, The supercritical fluid expands rapidly, producing an extremely fine solid dispersion containing everolimus.

[0035] 1.2 Preparation of Everolimus Tablets

[0036]

[0037]

[0038] The everolimus solid dispersion is mixed with lactose, sodium carboxymethyl starch and magnesium stearate, and compressed into tablets.

Embodiment 2

[0040] 1.1 Preparation of everolimus solid dispersion

[0041] Everolimus 1 part

[0042] 200 parts of absolute ethanol

[0043] 80 parts of hydroxypropyl cellulose

[0044] Preparation process: After dissolving everolimus in absolute ethanol, add hydroxypropyl cellulose, stir to dissolve, and then use supercritical fluid technology to prepare, and use supercritical fluid rapid expansion method to depressurize the solution through the nozzle and capillary, The supercritical fluid expands rapidly, producing an extremely fine solid dispersion containing everolimus.

[0045] 1.2 Preparation of Everolimus Tablets

[0046]

[0047] The everolimus solid dispersion is mixed with lactose, sodium carboxymethyl starch and magnesium stearate, and compressed into tablets.

Embodiment 3

[0049] 1.1 Preparation of everolimus solid dispersion

[0050] Everolimus 1 part

[0051] 20 parts absolute ethanol

[0052] 3 parts hydroxypropyl cellulose

[0053] Preparation process: After dissolving everolimus in absolute ethanol, add hydroxypropyl cellulose, stir to dissolve, and then use supercritical fluid technology to prepare, and use supercritical fluid rapid expansion method to depressurize the solution through the nozzle and capillary, The supercritical fluid expands rapidly, producing an extremely fine solid dispersion containing everolimus.

[0054] 1.2 Preparation of Everolimus Tablets

[0055]

[0056]

[0057] The everolimus solid dispersion is mixed with lactose, crospovidone and magnesium stearate, and compressed into tablets to obtain the product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a tablet containing everolimus, and a preparation method thereof. The tablet is prepared by tabletting of everolimus solid dispersion and a pharmaceutically acceptable auxiliary material, wherein the pharmaceutically acceptable auxiliary material comprises a filling material, a disintegrating agent and a lubricant. The everolimus solid dispersion is made of everolimus using a specific carrier material, so that hydrophilicity of everolimus is increased greatly, it is beneficial for rapid dissolving of everolimus in gastrointestinal tract body fluids, and medicine safety is improved.

Description

technical field [0001] The invention belongs to the technical field of western medicine preparations, and in particular relates to a tablet containing everolimus and a preparation method thereof. Background technique [0002] Everolimus is a derivative of sirolimus, an inhibitor of mTOR, a serine threonine kinase downstream of the PI3K / AKT pathway, which was first developed by Novartis, Switzerland. Launched in Sweden for the first time in 2003, everolimus can slow down the growth of renal cancer cells and reduce the mortality rate by 67%. By inhibiting the growth and proliferation of tumor cells, it directly acts on tumor cells; reduce and play an indirect role. [0003] Everolimus is a white to slightly yellow powder, lipophilic, and its solubility in water at 25°C is less than 0.01% (g / ml), so it is particularly important to improve its dissolution rate. [0004] Chinese patent CN102138903A discloses an oral pharmaceutical composition of everolimus, which overcomes the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/20A61K31/436A61K47/38A61P35/00
Inventor 赵志全郝贵周丁兵
Owner SHANDONG NEWTIME PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com